- Home
- PLRX vs VINP Comparison
PLRX vs VINP Comparison
Compare PLRX & VINP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PLRX
- VINP
- Stock Information
- Founded
- PLRX 2015
- VINP 2009
- Country
- PLRX United States
- VINP Brazil
- Employees
- PLRX N/A
- VINP N/A
- Industry
- PLRX Biotechnology: Pharmaceutical Preparations
- VINP Investment Managers
- Sector
- PLRX Health Care
- VINP Finance
- Exchange
- PLRX Nasdaq
- VINP Nasdaq
- Market Cap
- PLRX 89.0M
- VINP 636.2M
- IPO Year
- PLRX 2020
- VINP 2021
- Fundamental
- Price
- PLRX $1.46
- VINP $10.20
- Analyst Decision
- PLRX Hold
- VINP Strong Buy
- Analyst Count
- PLRX 10
- VINP 2
- Target Price
- PLRX $3.93
- VINP $13.50
- AVG Volume (30 Days)
- PLRX 692.5K
- VINP 36.3K
- Earning Date
- PLRX 11-06-2025
- VINP 11-06-2025
- Dividend Yield
- PLRX N/A
- VINP 6.41%
- EPS Growth
- PLRX N/A
- VINP N/A
- EPS
- PLRX N/A
- VINP 0.50
- Revenue
- PLRX N/A
- VINP $153,475,995.00
- Revenue This Year
- PLRX N/A
- VINP $68.12
- Revenue Next Year
- PLRX N/A
- VINP $14.85
- P/E Ratio
- PLRX N/A
- VINP $20.18
- Revenue Growth
- PLRX N/A
- VINP 76.11
- 52 Week Low
- PLRX $1.10
- VINP $8.66
- 52 Week High
- PLRX $16.10
- VINP $10.99
- Technical
- Relative Strength Index (RSI)
- PLRX 40.86
- VINP 58.84
- Support Level
- PLRX $1.66
- VINP $9.75
- Resistance Level
- PLRX $1.85
- VINP $10.09
- Average True Range (ATR)
- PLRX 0.12
- VINP 0.22
- MACD
- PLRX -0.03
- VINP 0.00
- Stochastic Oscillator
- PLRX 2.27
- VINP 84.91
About PLRX Pliant Therapeutics Inc.
Pliant Therapeutics Inc is a clinical-stage biopharmaceutical company focused on discovering and developing novel therapies for the treatment of fibrosis and related diseases. Its primary product candidate is bexotegrast (PLN-74809), an oral, small molecule, that the company is developing for the treatment of idiopathic pulmonary fibrosis, or IPF, and primary sclerosing cholangitis.
About VINP Vinci Partners Investments Ltd.
Vinci Compass Investments Ltd is an alternative investment platform in Brazil. Its business segments include Private Equity, Equities, Real Assets, Credit, Global IP&S, and Corporate Advisory. The company's majority of its revenue comes from the Private Equity segment, which is comprised of five business lines: private equity, real estate, infrastructure, credit, and special situations.